首页> Clinical chemistry> Generic Protocols for the Analytical Validation of Next-Generation Sequencing-Based ctDNA Assays: A Joint Consensus Recommendation of the BloodPAC's Analytical Variables Working Group.

Generic Protocols for the Analytical Validation of Next-Generation Sequencing-Based ctDNA Assays: A Joint Consensus Recommendation of the BloodPAC's Analytical Variables Working Group.

导出 OA

翻译打印收藏纠错

第一作者： James H,Godsey

第一单位： Illumina, San Diego, CA.

作者： James H,Godsey ^[1] ; Angela,Silvestro ^[2] ; J Carl,Barrett ^[3] ; Kelli,Bramlett ^[4] ; Darya,Chudova ^[5] ; Ina,Deras ^[1] ; Jennifer,Dickey ^[6] ; James,Hicks ^[7] ; Donald J,Johann ^[8] ; Rebecca,Leary ^[2] ; Jerry S H,Lee ^[7] ; Joe,McMullen ^[1] ; Lisa,McShane ^[9] ; Katherine,Nakamura ^[10] ; Aaron O,Richardson ^[5] ; Matthew,Ryder ^[11] ; John,Simmons ^[6] ; Kelli,Tanzella ^[12] ; Laura,Yee ^[9] ; Lauren C,Leiman ^[13]

作者单位： Illumina, San Diego, CA. ^[1] Novartis Pharmaceuticals, Cambridge, MA. ^[2] AstraZeneca, Waltham, MA. ^[3] Thermo Fisher Scientific, Austin, TX. ^[4] Guardant Health, Redwood City, CA. ^[5] Personal Genome Diagnostics, Baltimore, MD. ^[6] University of Southern California, Los Angeles, CA. ^[7] University of Arkansas, Little Rock, AR. ^[8] National Cancer Institute at the National Institutes of Health (NIH/NCI), Rockville, MD. ^[9] Thermo Fisher Scientific, Carlsbad, CA. ^[10] Sysmex Inostics, Baltimore, MD. ^[11] Thermo Fisher Scientific, Grand Island, NY. ^[12] BloodPAC, Chicago, IL. ^[13]

关键词 NGS analytical validation cfDNA ctDNA liquid biopsy plasma

医学主题词指导方针(主题)(Guidelines as Topic);高通量核苷酸序列分析(High-Throughput Nucleotide Sequencing);人类(Humans);肿瘤(Neoplasms);参考标准(Reference Standards);有效性研究(主题)(Validation Studies as Topic)

DOI 10.1093/clinchem/hvaa164

PMID 32870995

发布时间 2024-03-29

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交